Sialolithiasis)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Juvenile Recurrent Parotitis and Sialolithiasis: an Noteworthy Co-Existence
Otolaryngology Open Access Journal ISSN: 2476-2490 Juvenile Recurrent Parotitis and Sialolithiasis: An Noteworthy Co-Existence Venkata NR* and Sanjay H Case Report Department of ENT and Head & Neck Surgery, Kohinoor Hospital, India Volume 3 Issue 1 Received Date: April 20, 2018 *Corresponding author: Nataraj Rajanala Venkata, Department of ENT and Head & Published Date: May 21, 2018 Neck Surgery, Kohinoor Hospital, Kurla (W), Mumbai, India, Tel: +918691085580; DOI: 10.23880/ooaj-16000168 Email: [email protected] Abstract Juvenile Recurrent Parotitis is a relatively rare condition. Sialolithiasis co-existing along with Juvenile Recurrent Parotitis is an even rarer occurrence. We present a case of Juvenile Recurrent Parotitis and Sialolithiasis in a 6 years old male child and how we managed it. Keywords: Juvenile Recurrent Parotitis; Parotid gland; Swelling; Sialolithiasis Introduction child. Tuberculosis was suspected but the tests yielded no results. Even MRI of the parotid gland failed to reveal any Juvenile Recurrent Parotitis is characterized by cause. Then the patient was referred to us for definitive recurring episodes of swelling usually accompanied by management. Taking the history into consideration, a pain in the parotid gland. Associated symptoms usually probable diagnosis of Juvenile Recurrent Parotitis due to include fever and malaise. It is most commonly seen in sialectasis was considered. CT Sialography revealed children, but may persist into adulthood. Unlike parotitis, dilatation of the main duct and the ductules with which is caused by infection or obstructive causes like collection of the dye at the termination of the terminal calculi, fibromucinous plugs, duct stenosis and foreign ductules, in the left parotid gland. -
Sjogren's Syndrome an Update on Disease Pathogenesis, Clinical
Clinical Immunology 203 (2019) 81–121 Contents lists available at ScienceDirect Clinical Immunology journal homepage: www.elsevier.com/locate/yclim Review Article Sjogren’s syndrome: An update on disease pathogenesis, clinical T manifestations and treatment ⁎ Frederick B. Vivinoa, , Vatinee Y. Bunyab, Giacomina Massaro-Giordanob, Chadwick R. Johra, Stephanie L. Giattinoa, Annemarie Schorpiona, Brian Shaferb, Ammon Peckc, Kathy Sivilsd, ⁎ Astrid Rasmussend, John A. Chiorinie, Jing Hef, Julian L. Ambrus Jrg, a Penn Sjögren's Center, Penn Presbyterian Medical Center, University of Pennsylvania Perelman School of Medicine, 3737 Market Street, Philadelphia, PA 19104, USA b Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, 51 N. 39th Street, Philadelphia, PA 19104, USA c Department of Infectious Diseases and Immunology, University of Florida College of Veterinary Medicine, PO Box 100125, Gainesville, FL 32610, USA d Oklahoma Medical Research Foundation, Arthritis and Clinical Immunology Program, 825 NE 13th Street, OK 73104, USA e NIH, Adeno-Associated Virus Biology Section, National Institute of Dental and Craniofacial Research, Building 10, Room 1n113, 10 Center DR Msc 1190, Bethesda, MD 20892-1190, USA f Department of Rheumatology and Immunology, Peking University People’s Hospital, Beijing 100044, China g Division of Allergy, Immunology and Rheumatology, SUNY at Buffalo School of Medicine, 100 High Street, Buffalo, NY 14203, USA 1. Introduction/History and lacrimal glands [4,11]. The syndrome is named, however, after an Ophthalmologist from Jonkoping, Sweden, Dr Henrik Sjogren, who in Sjogren’s syndrome (SS) is one of the most common autoimmune 1930 noted a patient with low secretions from the salivary and lacrimal diseases. It may exist as either a primary syndrome or as a secondary glands. -
Parotid Sialolithiasis and Sialadenitis in a 3-Year-Old Child
Ahmad Tarmizi et al. Egyptian Pediatric Association Gazette (2020) 68:29 Egyptian Pediatric https://doi.org/10.1186/s43054-020-00041-z Association Gazette CASE REPORT Open Access Parotid sialolithiasis and sialadenitis in a 3- year-old child: a case report and review of the literature Nur Eliana Ahmad Tarmizi1, Suhana Abdul Rahim2, Avatar Singh Mohan Singh2, Lina Ling Chooi2, Ong Fei Ming2 and Lum Sai Guan1* Abstract Background: Salivary gland calculi are common in adults but rare in the paediatric population. It accounts for only 3% of all cases of sialolithiasis. Parotid ductal calculus is rare as compared to submandibular ductal calculus. Case presentation: A 3-year-old boy presented with acute painful right parotid swelling with pus discharge from the Stensen duct. Computed tomography revealed calculus obstructing the parotid duct causing proximal ductal dilatation and parotid gland and masseter muscle oedema. The child was treated with conservative measures, and subsequently the swelling and calculus resolved. Conclusions: Small parotid duct calculus in children may be successfully treated with conservative measures which obviate the need for surgery. We discuss the management of parotid sialolithiasis in children and conduct literature search on the similar topic. Keywords: Sialolithiasis, Sialadenitis, Salivary calculi, Parotid gland, Salivary ducts, Paediatrics Background performing computed tomography (CT) of the neck. Sialolithiasis is an obstructive disorder of salivary ductal The unusual presentation, CT findings and its subse- system caused by formation of stones within the salivary quent management were discussed. gland or its excretory duct [1]. The resulting salivary flow obstruction leads to salivary ectasia, gland dilatation Case presentation and ascending infection [2]. -
Pratiqueclinique
Pratique CLINIQUE Sympathetically Maintained Pain Presenting First as Temporomandibular Disorder, then as Parotid Dysfunction Auteur-ressource Subha Giri, BDS, MS; Donald Nixdorf, DDS, MS Dr Nixdorf Courriel : nixdorf@ umn.edu SOMMAIRE Le syndrome douloureux régional complexe (SDRC) est un état chronique qui se carac- térise par une douleur intense, de l’œdème, des rougeurs, une hypersensibilité et des effets sudomoteurs accrus. Dans les 13 cas de SDRC siégeant dans la région de la tête et du cou qui ont été recensés dans la littérature, il a été établi que l’étiologie de la douleur était une lésion nerveuse. Dans cet article, nous présentons le cas d’une femme de 30 ans souffrant de douleur maintenue par le système sympathique, sans lésion nerveuse appa- rente. Ses principaux symptômes – douleur préauriculaire gauche et incapacité d’ouvrir grand la bouche – simulaient une arthralgie temporomandibulaire et une douleur myo- faciale des muscles masticateurs. Puis sont apparus une douleur préauriculaire intermit- tente et de l’œdème accompagnés d’hyposalivation – des signes cette fois-ci évocateurs d’une parotidite. Après une évaluation diagnostique exhaustive, aucune pathologie sous-jacente précise n’a pu être déterminée et un diagnostic de douleur névropathique à forte composante sympathique a été posé. Deux ans après l’apparition des symptômes et le début des soins, un traitement combinant des blocs répétés du ganglion cervico- thoracique et une pharmacothérapie (clonidine en perfusion entérale) a procuré un sou- lagement adéquat de la douleur. Mots clés MeSH : complex regional pain syndrome; pain, intractable; parotitis; temporomandibular joint disorders Pour les citations, la version définitive de cet article est la version électronique : www.cda-adc.ca/jcda/vol-73/issue-2/163.html omplex regional pain syndrome (CRPS) • onset following an initiating noxious is a chronic condition that usually affects event (CRPS-type I) or nerve injury (CRPS- Cextremities, such as the arms or legs. -
Current Opinions in Sialolithiasis Diagnosis and Treatment Attuali Conoscenze Nella Diagnosi E Trattamento Della Scialolitiasi
ACTA OTORHINOLARYNGOL ITAL 25, 145-149, 2005 ROUND TABLE 91ST NATIONAL CONGRESS S.I.O. Current opinions in sialolithiasis diagnosis and treatment Attuali conoscenze nella diagnosi e trattamento della scialolitiasi M. ANDRETTA, A. TREGNAGHI1, V. PROSENIKLIEV, A. STAFFIERI ORL Clinic, Department of Surgery; 1 Institute of Radiology, University of Padua, Italy Key words Parole chiave Salivary glands • Sialolithiasis • Diagnosis • Treatment • Ghiandole salivari • Litotrissia • Diagnosi • Terapia • Sialo-MRI • Lithotripsy Scialo-RM • Scialolitiasi Summary Riassunto The introduction, 15 years ago, of extracorporeal shock L’introduzione, 15 anni fa, della litotrissia extracorporea con wave lithotripsy in the treatment of salivary gland calculi, onde d’urto (ESWL) nella terapia della calcolosi salivare ha has changed the therapeutic approach in these patients. Aim cambiato radicalmente l’approccio terapeutico di questi pa- of this study was to evaluate the efficacy of lithotripsy in zienti. L’obiettivo del nostro studio è stato quello di valutare sialolithiasis, after 10 years follow-up. A review has been l’efficacia terapeutica della litotrissia nei pazienti con scialo- made of the literature to establish current opinions in diag- litiasi, tramite un follow-up a lungo termine (10 anni). È stata, nosis and treatment of sialolithiasis. The role of ultra- inoltre, effettuata una revisione della letteratura con lo scopo sonography, radiography and, in particular, of sialo- di valutare le attuali conoscenze riguardanti la diagnosi e la magnetic resonance imaging in diagnosis of salivary lithi- terapia di questa patologia. È stato, poi, valutato il ruolo del- asis has been evaluated. The greater efficiency of the extra- l’ecografia, della radiografia ed in particolare della scialo- corporeal shock wave lithotripsy treatment for parotid, RM nella diagnosi di calcolosi salivare. -
Sialolithiasis of Minor Salivary Glands
+ MODEL Journal of Dental Sciences (2015) xx,1e4 Available online at www.sciencedirect.com ScienceDirect journal homepage: www.e-jds.com ORIGINAL ARTICLE Sialolithiasis of minor salivary glands: A review of 17 cases Wen-Chen Wang a,b,c, Ching-Yi Chen c, Hen-Jen Hsu e, Jer-Haur Kuo b,c, Li-Min Lin b,c,d, Yuk-Kwan Chen b,c,d* a Dental Department, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan b School of Dentistry, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan c Division of Oral Pathology & Maxillofacial Radiology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan d Oral & Maxillofacial Imaging Center, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan e Division of Oral & Maxillofacial Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan Received 22 July 2015; Final revision received 18 September 2015 Available online --- KEYWORDS Abstract Background/purpose: To our knowledge, sialolithiasis in minor salivary glands is minor salivary gland; very rare, and information about the disease is limited. The current study aimed to provide sialolith; updated data regarding the disease in Taiwan. The data were compared with those of previous sialolithiasis case series studies. Materials and methods: The features of 17 cases of histopathologically confirmed sialolithiasis in minor salivary glands between 1991 and 2015 in our institution were retrospectively analyzed. Results: Most of the patients were male (n Z 14; 82.35%), with only three female patients (17.65%). The mean age of the 17 patients was 62.93 years (range, 35e82 years). Fifteen cases (w88%) were found within the 6the9th decades. Seven cases (w41%) were identified in patients aged 70 years, six of which had been diagnosed in the most recent 5 years (2011e2015). -
Orofacial Manifestations of COVID-19: a Brief Review of the Published Literature
CRITICAL REVIEW Oral Pathology Orofacial manifestations of COVID-19: a brief review of the published literature Esam HALBOUB(a) Abstract: Coronavirus disease 2019 (COVID-19) has spread Sadeq Ali AL-MAWERI(b) exponentially across the world. The typical manifestations of Rawan Hejji ALANAZI(c) COVID-19 include fever, dry cough, headache and fatigue. However, Nashwan Mohammed QAID(d) atypical presentations of COVID-19 are being increasingly reported. Saleem ABDULRAB(e) Recently, a number of studies have recognized various mucocutaneous manifestations associated with COVID-19. This study sought to (a) Jazan University, College of Dentistry, summarize the available literature and provide an overview of the Department of Maxillofacial Surgery and potential orofacial manifestations of COVID-19. An online literature Diagnostic Sciences, Jazan, Saudi Arabia. search in the PubMed and Scopus databases was conducted to retrieve (b) AlFarabi College of Dentistry and Nursing, the relevant studies published up to July 2020. Original studies Department of Oral Medicine and published in English that reported orofacial manifestations in patients Diagnostic Sciences, Riyadh, Saudi Arabia. with laboratory-confirmed COVID-19 were included; this yielded 16 (c) AlFarabi College of Dentistry and Nursing, articles involving 25 COVID-19-positive patients. The results showed a Department of Oral Medicine and Diagnostic Sciences, Riyadh, Saudi Arabia. marked heterogeneity in COVID-19-associated orofacial manifestations. The most common orofacial manifestations were ulcerative lesions, (d) AlFarabi College of Dentistry and Nursing, Department of Restorative Dental Sciences, vesiculobullous/macular lesions, and acute sialadentitis of the parotid Riyadh, Saudi Arabia. gland (parotitis). In four cases, oral manifestations were the first signs of (e) Primary Health Care Corporation, Madinat COVID-19. -
Oral Manifestations of Systemic Disease Their Clinical Practice
ARTICLE Oral manifestations of systemic disease ©corbac40/iStock/Getty Plus Images S. R. Porter,1 V. Mercadente2 and S. Fedele3 provide a succinct review of oral mucosal and salivary gland disorders that may arise as a consequence of systemic disease. While the majority of disorders of the mouth are centred upon the focus of therapy; and/or 3) the dominant cause of a lessening of the direct action of plaque, the oral tissues can be subject to change affected person’s quality of life. The oral features that an oral healthcare or damage as a consequence of disease that predominantly affects provider may witness will often be dependent upon the nature of other body systems. Such oral manifestations of systemic disease their clinical practice. For example, specialists of paediatric dentistry can be highly variable in both frequency and presentation. As and orthodontics are likely to encounter the oral features of patients lifespan increases and medical care becomes ever more complex with congenital disease while those specialties allied to disease of and effective it is likely that the numbers of individuals with adulthood may see manifestations of infectious, immunologically- oral manifestations of systemic disease will continue to rise. mediated or malignant disease. The present article aims to provide This article provides a succinct review of oral manifestations a succinct review of the oral manifestations of systemic disease of of systemic disease. It focuses upon oral mucosal and salivary patients likely to attend oral medicine services. The review will focus gland disorders that may arise as a consequence of systemic upon disorders affecting the oral mucosa and salivary glands – as disease. -
For Immediate Release
For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Takashi Shoda, President and CEO (Code no.: 4568, First Section, Tokyo, Osaka, and Nagoya Stock Exchanges) Please address inquiries to Toshiaki Sai, General Manager, Corporate Communications Department Telephone: +81-3-6225-1126 http://www.daiichisankyo.com/ Daiichi Sankyo Launches new Cravit® Formulations in Japan TOKYO, Japan (July 7, 2009) – Daiichi Sankyo Company, Limited (TSE: 4568), today launched new formulations of Cravit® (generic name: Levofloxacin Hydrate), a broad-spectrum oral anti-bacterial agent. These formulations are 500mg and 250mg tablets, and a 10% fine granular preparation in Japan. The company obtained manufacturing and marketing approval on April 22. The drug price listing was on June 19. Daiichi Sankyo drew on PK-PD theory (see note below) to develop the once-daily dosage for the 500mg Cravit® tablet. This tablet lifts the maximum blood concentration and is significantly more bactericidal than the 100mg formulation, taken three times daily, suppressing the development of drug-resistant bacteria. The once-daily dosage of the Cravit® 500mg tablet is an approved standard in more than 120 countries and territories. Since its introduction in December 1993 in Japan, Cravit® has gained approval for treating 43 indications and 32 bacteria. This agent continues to offer outstanding efficacy, and has won accolades for its safety profile. Daiichi Sankyo is confident that its concept of a once-daily dosage of a 500mg tablet will win broad acceptance for improved efficacy and a better suppression of strong bacteria. The company will cultivate this product as a worthy contributor to long-term treatment. -
Prevalence of Salivary Gland Disease in Patients Visiting a Private Dental
European Journal of Molecular & Clinical Medicine ISSN 2515-8260 Volume 07, Issue 01, 2020 PREVALENCE OF SALIVARY GLAND DISEASE IN PATIENTS VISITING A PRIVATE DENTAL COLLEGE 1Dr.Abarna Jawahar, 2Dr.G.Maragathavalli, 3Dr.Manjari Chaudhary 1Department of Oral Medicine and Radiology, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India 2Professor, Department of Oral Medicine and Radiology, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences(SIMATS), Saveetha University, Chennai, India 3Senior Lecturer, Department of Oral Medicine and Radiology, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences(SIMATS), Saveetha University, Chennai, India [email protected] [email protected] [email protected] ABSTRACT: The aim of the study was to estimate the prevalence of salivary gland diseases in patients visiting a private dental college. A retrospective analysis was conducted on patients who visited the Department of Oral Medicine from March 2019 to March 2020.Clinically diagnosed cases of salivary gland diseases which included salivary gland neoplasms, xerostomia, necrotizing sialometaplasia, mucocele, ranula, sjogren’s syndrome, sialodochitis, sialadenitis were included in the study.The details of each case were reviewed from an electronic database.From the study we found that 17 patients were diagnosed with salivary gland disease.The most commonly observed salivary gland disease was mucocele of the lip with a frequency of 41.17% in the study population followed by xerostomia (17.65%).Salivary gland disease can occur due to variable causes and might significantly affect the quality of life and daily functioning.Only with a thorough knowledge of the subject it is possible to detect the diseases of the salivary gland in their early stage and manage them more efficiently. -
Salivary Gland Imaging in Sjogren's Syndrome
REVIEW Salivary gland imaging in Sjogren’s syndrome Susan I Lemon, Sjogren’s syndrome (SS) is a systemic connective tissue disease characterized by a Steven G Imbesi & progressive immune-mediated impairment of the exocrine glands. The high prevalence in Alexander R Shikhman† the general population of sicca and other symptoms mimicking SS has increased the need †Author for correspondence for accurate tools in its diagnosis. Imaging may be substantially helpful in this regard, as Scripps Clinic, Member of the well as in the assessment of acute and chronic complications of the disease. A future Division of Rheumatology, MS113, 10666 North Torrey, application of salivary imaging in SS may be guiding therapeutics by enabling Pines Road, La Jolla, radiographic monitoring of treatment responsiveness. This review of salivary gland imaging CA 92037, USA in SS summarizes the types of information yielded by currently available modalities and Tel.: +1 858 554 8562; suggests their proper clinical application. It emphasizes recent advances in noninvasive Fax: +1 858 554 6763; imaging, including magnetic resonance sialography, ultrasonography and nuclear [email protected] medicine techniques. Sjogren’s syndrome (SS) is a systemic connective atrophic and, finally, destroyed [8]. Eventually, the tissue disease characterized by a progressive only remaining ductal epithelium consists of iso- immune-mediated impairment of the exocrine lated cell clusters of epithelial and myoepithelial glands [1,2]. Common clinical manifestations of cells surrounded by a dense lymphocytic infiltra- exocrine involvement in SS include keratocon- tion (a benign lymphoepithelial lesion) [9]. These junctivitis sicca, xerostomia and episodic glandu- pathological changes lead to salivary gland hypo- lar swelling. -
Clinical Features and Histological Description of Tongue Lesions in a Large Northern Italian Population
Med Oral Patol Oral Cir Bucal. 2015 Sep 1;20 (5):e560-5. Retrospective study on tongue lesions Journal section: Oral Medicine and Pathology doi:10.4317/medoral.20556 Publication Types: Research http://dx.doi.org/doi:10.4317/medoral.20556 Clinical features and histological description of tongue lesions in a large Northern Italian population Alessio Gambino 1, Mario Carbone 1, Paolo-Giacomo Arduino 1, Marco Carrozzo 2, Davide Conrotto 1, Carlotta Tanteri 1, Lucio Carbone 3, Alessandra Elia 1, Zaira Maragon 3, Roberto Broccoletti 1 1 Department of Surgical Sciences, Oral Medicine Section, CIR - Dental School, University of Turin, Turin, Italy 2 Oral Medicine Department, Centre for Oral Health Research, Newcastle University, Newcastle upon Tyne, UK 3 Private practice, Turin Correspondence: Oral Medicine Section University of Turin CIR – Dental School Gambino A, Carbone M, Arduino PG, Carrozzo M, Conrotto D, Tanteri Via Nizza 230, 10126 C, Carbone L, Elia A, Maragon Z, Broccoletti R. Clinical features and Turin, Italy histological description of tongue lesions in a lar�������������������������ge Northern Italian popu- [email protected] lation. Med Oral Patol Oral Cir Bucal. 2015 Sep 1;20 (5):e560-5. http://www.medicinaoral.com/medoralfree01/v20i5/medoralv20i5p560.pdf Article Number: 20556 http://www.medicinaoral.com/ Received: 21/12/2014 © Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946 Accepted: 25/04/2015 eMail: [email protected] Indexed in: Science Citation Index Expanded Journal Citation Reports Index Medicus, MEDLINE, PubMed Scopus, Embase and Emcare Indice Médico Español Abstract Background: Only few studies on tongue lesions considered sizable populations, and contemporary literature does not provide a valid report regarding the epidemiology of tongue lesions within the Italian population.